Immunotherapy Trials

Hi I am reaching out to ask if anyone is currently doing any trials in immunotherapy for high grade serious platinum resistant ov cancer. My oncologist here in Kelowna, BC is checking into 2 of these that is currently enrolling ovarian cancer patients. I was considered platinum resistant after my tumors reoccured after last 3 chemo after surgery. The parp did not work and so therefore went on Avastan and Caeylx which worked and my latest CT scan in July 2022 showed no new tumors and existing ones show stable and shrinkage.
 my CA125 levels are now climbing as my oncologist feels it is no longer working. Before we continue with another chemo regiment my oncologist is checking into 2 trials.

1trial is Immunotherapy platform study in platinum Restistant high grade ovarian cancer.

 Durvalumab in combination with Bio Atla's BA3011 (mecbotamab vedotin) or Durvalumab in combination with Bio Atla's BA3021 (ozuriftamab vedotin).

Is anyone currently on this trial or was and if so how did your fair?   With side effects or results so far. I do realize everyone does react differently for side effects.

The 2nd trial is ....Study of TSR-042 an anti programmed cell death-1 receptor (pd-1) Monoclonal Antibody in participants with advanced solid tumor.
The drug is Dostarlimab.
Is anyone currently on this trial and if so how are you doing on it and has it shown to be effective. ( again i realize everyone can react differently for side effects and results) i did find some info about the 1sr trial i mentioned and can post the info i found.

Comments

Sign In or Register to comment.